OBINNA ANYANWU: Open Payments
NPI 1659141273 · NEWTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 30 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $509 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $325 |
| Otsuka America Pharmaceutical, Inc. | 5 | $191 |
| Alkermes, Inc. | 2 | $140 |
| Supernus Pharmaceuticals, Inc. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
Products named: VRAYLAR, REXULTI, LYBALVI, Qelbree, ARISTADA, UZEDY, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
